Search hospitals > Quebec > GREENFIELD PARK
Hopital Charles Lemoyne
Claim this profileGREENFIELD PARK, Quebec J4V 2H1
Global Leader in Breast Cancer
Global Leader in Colorectal Cancer
Conducts research for Leukemia
Conducts research for Lymphoma
Conducts research for Cancer
104 reported clinical trials
5 medical researchers
Summary
Hopital Charles Lemoyne is a medical facility located in GREENFIELD PARK, Quebec. This center is recognized for care of Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Cancer and other specialties. Hopital Charles Lemoyne is involved with conducting 104 clinical trials across 107 conditions. There are 5 research doctors associated with this hospital, such as Pierre Desjardins, Trung N. Nguyen, Melina Boutin, and Selvan Rajakesari.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
Stage I
2Colorectal Cancer
Global LeaderStage II
Stage III
MSS positive
Top PIs
Pierre DesjardinsHopital Charles-LeMoyne4 years of reported clinical research
Studies Leukemia
Studies Acute Lymphoblastic Leukemia
2 reported clinical trials
6 drugs studied
Trung N. NguyenCSSS Champlain-Charles Le Moyne4 years of reported clinical research
Studies Colon Cancer
Studies Colorectal Cancer
1 reported clinical trial
5 drugs studied
Melina BoutinCSSS Champlain-Charles Le Moyne2 years of reported clinical research
Studies Colon Cancer
Studies Colorectal Cancer
1 reported clinical trial
4 drugs studied
Selvan RajakesariCSSS Champlain-Charles Le Moyne5 years of reported clinical research
Studies Brain Tumor
Studies Cancer
1 reported clinical trial
3 drugs studied
Clinical Trials running at Hopital Charles Lemoyne
Breast Cancer
Brain Tumor
Cancer
Colon Cancer
Colorectal Cancer
Pain
Perineal Injury
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Giredestrant + Hormone Therapy
for Early-Stage Breast Cancer
This trial is testing giredestrant, a medication given after initial treatment to prevent breast cancer from returning. It focuses on patients with a specific type of early-stage breast cancer that is hormone-driven and at higher risk of recurrence. Giredestrant works by blocking the hormone estrogen from helping cancer cells grow. Giredestrant has shown promise in previous studies.
Recruiting2 awards Phase 311 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Hopital Charles Lemoyne?
Hopital Charles Lemoyne is a medical facility located in GREENFIELD PARK, Quebec. This center is recognized for care of Breast Cancer, Colorectal Cancer, Leukemia, Lymphoma, Cancer and other specialties. Hopital Charles Lemoyne is involved with conducting 104 clinical trials across 107 conditions. There are 5 research doctors associated with this hospital, such as Pierre Desjardins, Trung N. Nguyen, Melina Boutin, and Selvan Rajakesari.